Pfizer Inc. (PFE)
26.65
+0.21
(+0.79%)
USD |
NYSE |
Feb 02, 16:00
26.58
-0.07
(-0.26%)
After-Hours: 19:59
Pfizer Research and Development Expense (Quarterly) : 2.492B for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amgen, Inc. | 1.90B |
| Regeneron Pharmaceuticals, Inc. | 1.626B |
| Vertex Pharmaceuticals, Inc. | 977.70M |
| Viking Therapeutics, Inc. | 89.95M |
| Moderna, Inc. | 749.00M |